Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertension

Clinically significant portal hypertension (CSPH), defined as a hepatic venous pressure gradient (HVPG) ≥ 10 mmHg, is an independent risk factor for decompensated events in patients with compensated cirrhosis. Currently, the Baveno VII consensus recommends using nonselective beta‐blockers to treat c...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Portal hypertension & cirrhosis (Print) Ročník 2; číslo 2; s. 105 - 108
Hlavní autori:	Wang, Kun, Tian, Minghui, Zhang, Linpeng, Liu, Shanghao, Guo, Xiaoqing, Ma, Jianzhong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Nanjing John Wiley & Sons, Inc 01.06.2023 Wiley
Predmet:	Abdomen Antigens Blood pressure Case reports Catheters Clinical significance Drug dosages Heart rate Hepatic venous pressure gradient Hepatitis B Hypertension Liver cancer Liver cirrhosis Liver diseases Medical imaging Medical prognosis Non‐selective beta‐blocker Patients Pharmacists Portal hypertension Veins & arteries
ISSN:	2770-5846, 2770-5838, 2770-5846
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!